Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Shardulendra P Sherchand"'
Publikováno v:
PLoS ONE, Vol 11, Iss 9, p e0163174 (2016)
Chlamydia trachomatis is an obligate intracellular pathogen that requires specific essential nutrients from the host cell, one of which is the amino acid tryptophan. In this context interferon gamma (IFNγ) is the major host protective cytokine again
Externí odkaz:
https://doaj.org/article/aff9141698a54fcb9a9a2e76504a1d25
Autor:
Yu Wang, Ipsita Mukherjee, Arundhathi Venkatasubramaniam, Dustin Dikeman, Nicholas Orlando, Jing Zhang, Roger Ortines, Mark Mednikov, Shardulendra P. Sherchand, Tulasikumari Kanipakala, Thao Le, Sanjay Shukla, Mark Ketner, Rajan P. Adhikari, Hatice Karauzum, M. Javad Aman, Nathan K. Archer
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Staphylococcus aureus is the leading cause of skin and soft tissue infections (SSTIs) in the U.S. as well as more serious invasive diseases, including bacteremia, sepsis, endocarditis, surgical site infections, osteomyelitis, and pneumonia. These inf
Externí odkaz:
https://doaj.org/article/9e8670e1737d41c3b9440e011a2c6162
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Externí odkaz:
https://doaj.org/article/45fcc97bad304b769f59d36ac109227c
Autor:
Xiaobing Han, Roger Ortines, Ipsita Mukherjee, Tulasikumari Kanipakala, Thomas Kort, Shardulendra P. Sherchand, Grant Liao, Mark Mednikov, Agnes L. Chenine, M. Javad Aman, Cory L. Nykiforuk, Rajan P. Adhikari
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Staphylococcus aureus has been acquiring multiple drug resistance and has evolved into superbugs such as Methicillin/Vancomycin-resistant S. aureus (MRSA/VRSA) and, consequently, is a major cause of nosocomial and community infections associated with
Externí odkaz:
https://doaj.org/article/8ed38ad2e8f142c89e8bcb9df02022af
Publikováno v:
Preventive Medicine Reports, Vol 8, Iss , Pp 67-71 (2017)
Epidemiological surveys conducted in general populations have found that the prevalence of depression is about 9% in the United States. World Health Organization has projected that depression will be leading cause of disease burden by the year 2030.
Externí odkaz:
https://doaj.org/article/41ee6efa430243289493f873a9bf2064
Autor:
R Shrestha, Rene S. Hendriksen, L Bhatta-Sharma, Bhatta, Shardulendra P. Sherchand, Samendra P. Sherchan, Dipendra Shrestha
Publikováno v:
Nepal Medical College Journal. 22:153-157
The chemokine receptor CCR5 exhibits an important role for the CD-4 mediated entry of HIV-1. Previous studies revealed that Δ32 mutation on the CCR5 gene results in truncated protein and hence confers protection against HIV-1 infection and AIDS prog
Autor:
Krishna Gurung, Krishna Panta, Keshab Parajuli, Nabaraj Adhikari, Ramesh Pun, Dev Raj Joshi, Shardulendra P. Sherchand, Dipendra Shrestha
Publikováno v:
Journal of Health and Allied Sciences. 1:12-15
na
Autor:
Ashok eAiyar, Alison J. Quayle, Lyndsey B. Buckner, Shardulendra P. Sherchand, Theresa L. Chang, Arnold H. Zea, David H. Martin, Robert J. Belland
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 4 (2014)
The natural history of genital Chlamydia trachomatis infections can vary widely; infections can spontaneously resolve but can also last from months to years, potentially progressing to cause significant pathology. The host and bacterial factors under
Externí odkaz:
https://doaj.org/article/11ad3471cdc34c16857589c9bbfb2bdc
Autor:
Ashok Aiyar, Takeshi Nagamatsu, Shardulendra P. Sherchand, Francis L. Fontanilla, Danny J. Schust, Joyce A. Ibana, Alison J. Quayle
Publikováno v:
Scientific Reports, Vol 8, Iss 1, Pp 1-15 (2018)
Scientific Reports
Scientific Reports
The intracellular bacterial pathogen, Chlamydia trachomatis, is a tryptophan auxotroph. Therefore, induction of the host tryptophan catabolizing enzyme, indoleamine-2,3-dioxgenase-1 (IDO1), by interferon gamma (IFNγ) is one of the primary protective
Publikováno v:
Preventive Medicine Reports, Vol 8, Iss, Pp 67-71 (2017)
Preventive Medicine Reports
Preventive Medicine Reports
Epidemiological surveys conducted in general populations have found that the prevalence of depression is about 9% in the United States. World Health Organization has projected that depression will be leading cause of disease burden by the year 2030.